60 results
Page 2 of 3
424B5
8dil9b
31 Dec 19
Prospectus supplement for primary offering
4:28pm
424B3
kaba 1en41r25bpgan
18 Nov 19
Prospectus supplement
4:53pm
8-K
EX-99.1
t88e5
9 Sep 19
Regulation FD Disclosure
6:50am
8-K
EX-99.1
6qk4op7
14 May 19
EyeGate Pharma Receives Positive Nasdaq Listing Determination
6:55am
8-K
EX-99.1
wisx1mtjb wj9gy58
12 Dec 18
Regulation FD Disclosure
4:30pm
8-K
EX-99.1
mc463qk4
13 Nov 18
Eyegate Pharma Announces Positive Results In Second PRK Study
7:00am
8-K
EX-99.2
cjlsaj ygpo5xdibczr
13 Nov 18
Eyegate Pharma Announces Positive Results In Second PRK Study
7:00am
8-K
EX-99.1
ef2m jpo90phbc
2 Oct 18
EyeGate Pharmaceuticals Signs Technology Transfer and License Agreement with SentrX Animal Care
6:58am
8-K
EX-99.1
a9nzg
25 Sep 18
EyeGate Pharmaceuticals Granted Additional 180 Days to Comply With Nasdaq Listing Rules
6:58am